sglt2 | Healthspan

(sglt2)

11 / 01 / 2025•8 MIN READ

SGLT-2 Inhibitors: Do They Differ in Their Potential for Healthspan Extension?

06 / 21 / 2025•29 MIN READ

The Case for Cyclical Longevity Protocols: How Rhythmic Activation of AMPK and Autophagy Reprograms Aging Cells

06 / 07 / 2025•20 MIN READ

The Energy Equation in Alzheimer’s Disease: Glucose-Driven Degeneration and Ketone-Driven Protection

05 / 30 / 2025•32 MIN READ

The Mitochondrial Signature of Long COVID: What PRDX3 Is Trying to Tell Us—And How We Might Reverse It

04 / 26 / 2025•14 MIN READ

Pharmacological Fasting: How SGLT-2 Inhibitors Emulate Caloric Restriction to Target Key Longevity Pathways

03 / 08 / 2025•28 MIN READ

SGLT2 Inhibitors as Metabolic Senolytics: Clearing Senescent Cells to Combat Pathological Aging

02 / 08 / 2025•19 MIN READ

Alzheimer’s Disease as Type 3 Diabetes: Evidence for Insulin Resistance and Metabolic Dysfunction as Drivers of AD Pathogenesis

01 / 25 / 2025•21 MIN READ

Mitochondria’s Paradoxical Role in Cancer Biology: Exploiting Metabolic Vulnerabilities for Therapeutic Targeting

01 / 18 / 2025•28 MIN READ

SGLT-2 Inhibitors in Aging and Healthspan: Surprising Mechanistic Insights Into Adipose Tissue Reduction, Lean Mass Preservation, and Longevity